CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $145,000 | +2.1% | 356,903 | -6.1% | 0.00% | 0.0% |
| Q3 2016 | $142,000 | -2.1% | 379,958 | -10.8% | 0.00% | +100.0% |
| Q2 2016 | $145,000 | -35.3% | 425,986 | +1.1% | 0.00% | -50.0% |
| Q1 2016 | $224,000 | -72.1% | 421,460 | -35.5% | 0.00% | -66.7% |
| Q4 2015 | $804,000 | -32.2% | 653,860 | -19.4% | 0.01% | -33.3% |
| Q3 2015 | $1,185,000 | -12.5% | 811,363 | +16.8% | 0.01% | +28.6% |
| Q2 2015 | $1,355,000 | +15.9% | 694,687 | +7.5% | 0.01% | 0.0% |
| Q1 2015 | $1,169,000 | – | 646,127 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,425,000 | $3,363,000 | 2.66% |
| ACUTA CAPITAL PARTNERS, LLC | 1,228,111 | $2,898,000 | 1.96% |
| Sio Capital Management, LLC | 505,000 | $1,192,000 | 0.94% |
| RA Capital Management | 2,500,000 | $5,900,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,000 | $1,770,000 | 0.30% |
| TFS CAPITAL LLC | 1,295,744 | $3,058,000 | 0.29% |
| EAGLE ASSET MANAGEMENT INC | 12,713,051 | $30,002,000 | 0.17% |
| JW Asset Management, LLC | 52,271 | $123,000 | 0.09% |
| Lombard Odier Asset Management (USA) Corp | 501,444 | $1,183,000 | 0.08% |
| First Heartland Consultants, Inc. | 74,624 | $176,000 | 0.07% |